BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Marshall PL, Nagy N, Kaber G, Barlow GL, Ramesh A, Xie BJ, Linde MH, Haddock NL, Lester CA, Tran QL, de Vries CR, Hargil A, Malkovskiy AV, Gurevich I, Martinez HA, Kuipers HF, Yadava K, Zhang X, Evanko SP, Gebe JA, Wang X, Vernon RB, de la Motte C, Wight TN, Engleman EG, Krams SM, Meyer EH, Bollyky PL. Hyaluronan synthesis inhibition impairs antigen presentation and delays transplantation rejection. Matrix Biol 2021;96:69-86. [PMID: 33290836 DOI: 10.1016/j.matbio.2020.12.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Karalis T, Skandalis SS. Hyaluronan network: a driving force in cancer progression. Am J Physiol Cell Physiol 2022. [PMID: 35649255 DOI: 10.1152/ajpcell.00139.2022] [Reference Citation Analysis]
2 Johnson LA, Jackson DG. Hyaluronan and Its Receptors: Key Mediators of Immune Cell Entry and Trafficking in the Lymphatic System. Cells 2021;10:2061. [PMID: 34440831 DOI: 10.3390/cells10082061] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Zanetti IR, Burgin M, Zhang L, Yeh ST, Ambadapadi S, Kilbourne J, Yaron JR, Lowe KM, Daggett-vondras J, Fonseca D, Boyd R, Wakefield D, Clapp W, Lim E, Chen H, Lucas A. Virus-Derived Chemokine Modulating Protein Pre-Treatment Blocks Chemokine–Glycosaminoglycan Interactions and Significantly Reduces Transplant Immune Damage. Pathogens 2022;11:588. [DOI: 10.3390/pathogens11050588] [Reference Citation Analysis]